SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Commonwealth Thoroughbreds LLC (CIK 0001789339) — Mar 12, 2020

Commonwealth Thoroughbreds LLC (CIK 0001789339)
Date: March 12, 2020 · CIK: 0001789339 · Accession: 0000000000-20-002231

AI Filing Summary & Sentiment

File numbers found in text: 024-11130

Date
March 12, 2020
Author
Not clearly detected
Form
UPLOAD
Company
Commonwealth Thoroughbreds LLC (CIK 0001789339)

Letter

March 12, 2020 Brian Doxtator Chief Executive Officer Commonwealth Thoroughbreds LLC 1450 North Broadway Lexington, Kentucky 40505 Re:Commonwealth Thoroughbreds LLC Amendment No. 2 to Offering Statement on Form 1-A Filed March 3, 2020 File No. 024-11130 Dear Mr. Doxtator: We have reviewed your amended offering statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your offering statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your offering statement and the information you provide in response to this comment, we may have additional comments. Amendment No. 2 to Offering Statement on Form 1-A filed March 3, 2020 General 1.We note that section 8.b. of your subscription agreement contains a provision stating that "[e]ach party to this Agreement hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this agreement or the transactions contemplated hereby." Please amend your filing to clearly disclose whether this provision applies to federal securities law claims, and amend your risk factor disclosure accordingly. In this regard, we note that your risk factor disclosure on page 35 already highlights risks related to a jury trial waiver provision in your operating agreement, but not in your subscription agreement. If this provision is not intended to apply to federal securities law claims, please amend your exhibit to state the same, or tell us how you will inform future investors of this limitation.

FirstName LastNameBrian Doxtator Comapany NameCommonwealth Thoroughbreds LLC March 12, 2020 Page 2 FirstName LastName Brian Doxtator Commonwealth Thoroughbreds LLC March 12, 2020 Page 2 Please contact Katherine Bagley at (202) 551-2545 or Mara Ransom at (202) 551- 3264 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Alan K. MacDonald

Show Raw Text
March 12, 2020
Brian Doxtator
Chief Executive Officer
Commonwealth Thoroughbreds LLC
1450 North Broadway
Lexington, Kentucky 40505
Re:Commonwealth Thoroughbreds LLC
Amendment No. 2 to Offering Statement on Form 1-A
Filed March 3, 2020
File No. 024-11130
Dear Mr. Doxtator:
            We have reviewed your amended offering statement and have the following comment.  In
our comment, we may ask you to provide us with information so we may better understand your
disclosure.
            Please respond to this letter by amending your offering statement and providing the
requested information.  If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your offering statement and the information you
provide in response to this comment, we may have additional comments.
Amendment No. 2 to Offering Statement on Form 1-A filed March 3, 2020
General
1.We note that section 8.b. of your subscription agreement contains a provision stating that
"[e]ach party to this Agreement hereby irrevocably waives, to the fullest extent permitted
by applicable law, any and all right to trial by jury in any legal proceeding arising out of
or relating to this agreement or the transactions contemplated hereby."  Please amend your
filing to clearly disclose whether this provision applies to federal securities law claims,
and amend your risk factor disclosure accordingly.  In this regard, we note that your risk
factor disclosure on page 35 already highlights risks related to a jury trial waiver provision
in your operating agreement, but not in your subscription agreement.  If this provision is
not intended to apply to federal securities law claims, please amend your exhibit to state
the same, or tell us how you will inform future investors of this limitation.

 FirstName LastNameBrian Doxtator
 Comapany NameCommonwealth Thoroughbreds LLC
 March 12, 2020 Page 2
 FirstName LastName
Brian Doxtator
Commonwealth Thoroughbreds LLC
March 12, 2020
Page 2
            Please contact Katherine Bagley at (202) 551-2545 or Mara Ransom at (202) 551-
3264 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       Alan K. MacDonald